Clinical Trial Update: Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study assesses the efficacy and safety of teplizumab in Japanese participants with Stage 2 Type 1 Diabetes. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Teplizumab (Teplizumab)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: RECRUITING